Pancreatic Cancer – Research & Answers

CancerJun 4, 2026

Stage 4 Pancreatic Cancer: Survival Ranges From Months to Years

Stage 4 pancreatic cancer carries one of the hardest prognoses in oncology, with typical survival measured in months. But buried in those statistics is a wide range. Median overall survival sits at 3 to 11 months with current standard chemotherapy, yet some patients, particularly those with limited metastases, good physical health, and responsive tumors, live several years and occasionally reach long-term remission. The difference between the short end and the long end of that range is not luck. It maps to specific, identifiable factors. Understanding which factors matter, and which treatments apply to which situations, is the most practical thing you can do with a stage 4 diagnosis. The research paints a clearer picture than most people expect.

Digestive DisordersJun 4, 2026

Pancreatic Elastase: One Stool Test, Three Very Different Answers Depending on Your Number

A single stool sample can tell you whether your pancreas is doing its job. Fecal elastase-1 (FE-1), a digestive enzyme produced by your pancreas, stays remarkably stable as it travels through your entire digestive tract. That stability makes it one of the most practical, non-invasive ways to assess exocrine pancreatic function, which is your pancreas's ability to produce the enzymes needed to digest food. But the test has a significant blind spot: it reliably catches moderate-to-severe pancreatic insufficiency while frequently missing mild cases. That distinction matters. If your doctor orders this test, understanding where your number falls, and what that number can and cannot tell you, is the difference between appropriate next steps and unnecessary anxiety or false reassurance.